focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.00
Ask: 10.00
Change: -0.50 (-5.00%)
Spread: 1.00 (11.111%)
Open: 9.50
High: 9.50
Low: 9.50
Prev. Close: 10.00
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

14 Oct 2022 07:00

RNS Number : 9197C
Aura Energy Limited
14 October 2022
 

 

14 October 2022

Aura Energy Limited

 

Issue of Equity

 

 

Aura Energy Limited (ASX:AEE, AIM:AURA) ("Aura", the "Company") a company focused on the development of the 85% owned Tiris Uranium Project, Mauritania, advises that an Appendix 2A (Application for quotation of securities) has been filed with the Australian Securities Exchange ("ASX") and is available on the Company's website: https://www.auraenergy.com.au/investor-centre/#asx

The Company has issued 11,569,585 ordinary shares at an exercise price of A$0.052 each arising from an exercise of options ("New Shares").

Application will be made for the 11,569,585 New Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 21 October 2022.

 

Total Voting Rights

Following the issue of the 11,569,585 New Shares, the total issued share capital of the Company will consist of 530,548,683 ordinary shares of no par value each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore, the total current voting rights in the Company following Admission will be 530,548,683 and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For Further Information, please contact:

Will Goodall

Acting CEO

Aura Energy Limited

info@auraenergy.com.au

 

Jane Morgan

JMM

Investor & Media Relations

info@janemorganmanagement.com.au

+61 405 555 618

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

David Hignell

Kasia Brzozowska

+44 (0) 203 470 0470

 

WH Ireland Limited

(Joint Broker)

Jessica Cave

Andrew de Andrade

+44 (0) 207 220 1666

 

 

 

About Aura Energy (ASX:AEE, AIM:AURA)

 

Aura Energy is an Australian-based minerals company with major uranium and polymetallic projects with large resources in Africa and Europe. The Company is principally focused on initial uranium production at its Tiris Uranium Project, an evolving major greenfields uranium discovery in Mauritania, with Aura announcing a Resource Upgrade in August 2021, bringing the total JORC Resource to 56 Mlbs (at a 100 ppm U3O8 lower cut-off grade).

Aura also completed a 2021 capital estimate update for the Tiris Definitive Feasibility Study, to reflect current global pricing, reconfirming Tiris as one of the lowest capex, lowest operating cost uranium projects slated for development.

In October 2021, the Company entered a US$10m Offtake Financing Agreement with Curzon, which includes an additional up to US$10m facility, bringing the maximum available under the agreement to US$20m.

In 2022, Aura will continue to transition from an advanced uranium explorer to uranium producer, to capitalise on the growing appetite for nuclear power as a critical, baseload, near-zero-carbon energy source to help drive the global shift towards decarbonising energy generation.

 
 

 
@AuraEnergyAEE  

 
https://www.linkedin.com/company/aura-energy-limited

Subscribe for Investor Updates

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFLEITLSLIF
Date   Source Headline
29th Nov 20238:50 amRNSResult of AGM
29th Nov 20237:00 amRNSNew Tiris Project Tenements Applications
21st Nov 20237:27 amRNSIssue of Equity
16th Nov 20238:20 amRNSIssue of Equity
10th Nov 20237:25 amRNSIssue of Equity
10th Nov 20237:21 amRNSNew Corporate Presentation
3rd Nov 20238:10 amRNSTotal Voting Rights
1st Nov 20237:55 amRNSNew Corporate Presentation
31st Oct 20237:51 amRNSAnnual Report & Notice of Annual General Meeting
30th Oct 20237:49 amRNSQuarterly Report for Period Ending 30 September 23
30th Oct 20237:41 amRNSIssue of Equity
17th Oct 20237:00 amRNSNew Uranium Exploration Target
13th Oct 20238:35 amRNSIssue of Equity
11th Oct 20238:05 amRNSIssue of Equity
4th Oct 20238:26 amRNSTotal Voting Rights
28th Sep 202310:46 amRNSIssue of Equity
26th Sep 202312:26 pmRNSFinancial Report for the year ended 30 June 23
26th Sep 20238:38 amRNSIssue of Equity
21st Sep 20237:24 amRNSIssue of Equity
14th Sep 20237:10 amRNSHolding(s) in Company
12th Sep 20237:00 amRNSChange of Company Secretary
5th Sep 20238:07 amRNSHäggån Scoping Study
31st Aug 20237:00 amRNSChange of share registry address
31st Aug 20237:00 amRNSIssue of Equity
31st Aug 20237:00 amRNSTotal Voting Rights
17th Aug 20237:27 amRNSIssue of Equity
4th Aug 20237:00 amRNSChange of registered office
31st Jul 20237:17 amRNSQuarterly Report for the Period Ending 30 June 23
27th Jul 20237:58 amRNSIssue of Equity
17th Jul 20237:57 amRNSHoldings in Company
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20238:01 amRNSHoldings in Company
20th Jun 20237:00 amRNSSuccessful Share Purchase Plan Completed
9th Jun 20237:00 amRNSShare Purchase Plan offer closing on 13 June 2023
2nd Jun 20237:00 amRNSIssue of Equity
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSIssue of Equity
17th May 20237:00 amRNSCleansing Notice
16th May 20237:00 amRNSHoldings in Company
10th May 20237:07 amRNSCleansing Notice
3rd May 20237:18 amRNSA$10 million Placement to Support its Project
2nd May 20237:00 amRNSASX Trading Halt
28th Apr 20237:45 amRNSQuarterly Report for the Period Ending 31 March 23
4th Apr 20237:10 amRNSExpiry of options
4th Apr 20237:00 amRNSASX Trading Halt Update
3rd Apr 20239:52 amRNSUpdate on uranium mining ban in Sweden
3rd Apr 20238:42 amRNSDirector Dealing
31st Mar 202311:05 amRNSSecond Price Monitoring Extn
31st Mar 202311:00 amRNSPrice Monitoring Extension
31st Mar 20239:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.